Lattice_grid_med
Powered by LatticeGrid

Search Enter term and hit return. Use '*' for as a wildcard.

Publication Listing for 2019 (595 publications)

no pagination
Chen M, Fan L, Zhang SM, Li Y, Chen P, Peng X, Liu DB, Ma C, Zhang WJ, Zou ZW, Li PD. LINC01939 inhibits the metastasis of gastric cancer by acting as a molecular sponge of miR-17-5p to regulate EGR2 expression. Cell Death and Disease. 2019 Jan;10(2).
Chung W, Kelly AD, Kropf P, Fung H, Jelinek J, Su XY, Roboz GJ, Kantarjian HM, Azab M, Issa JP. Genomic and epigenomic predictors of response to guadecitabine in relapsed/refractory acute myelogenous leukemia. Clinical epigenetics. 2019 Jan;11(1).
Chwistek M. Cancer, Cannabis, and the search for relief. JNCCN Journal of the National Comprehensive Cancer Network. 2019 Jan;17(9):1142-4.
Cole S, Zibelman M, Bertino E, Yucebay F, Reynolds K. Managing Immuno-Oncology Toxicity: Top 10 Innovative Institutional Solutions. American Society of Clinical Oncology educational book American Society of Clinical Oncology Meeting. 2019 Jan;39:96-104.
Correa AF, Uzzo RG. Author Response. Urology. 2019 Jan;123:179-80.
Correa AF, Yankey H, Li T, Joshi SS, Kutikov A, Chen DY, Viterbo R, Greenberg RE, Smaldone MC, Uzzo RG. Renal Hilar Lesions: Biological Implications for Complex Partial Nephrectomy. Urology. 2019 Jan;123:174-80.
Davis SL, Cardin DB, Shahda S, Lenz HJ, Dotan E, O’Neil BH, Kapoun AM, Stagg RJ, Berlin J, Messersmith WA, Cohen SJ. A phase 1b dose escalation study of Wnt pathway inhibitor vantictumab in combination with nab-paclitaxel and gemcitabine in patients with previously untreated metastatic pancreatic cancer. Investigational New Drugs. 2019 Jan;.
de Prisco N, Stout E, Font-Burgada J. Specific Labeling and Lineage Tracing of Periportal Hepatocytes Using Two-Step Genetic Recombination. Methods Mol Biol. 2019 Jan;1905:59-70.
Drilon A, Fu S, Patel MR, Fakih M, Wang D, Olszanski AJ, Morgensztern D, Liu SV, Cho BC, Bazhenova L, Rodriguez CP, Doebele RC, Wozniak A, Reckamp KL, Seery T, Nikolinakos P, Hu Z, Oliver JW, Trone D, McArthur K, Patel R, Multani PS, Ahn MJ. A phase I/IB trial of the vegfr-sparing multikinase ret inhibitor RXDX-105. Cancer discovery. 2019 Jan;9(3):384-95.
El-Deiry WS, Winer A, Slifker M, Taylor S, Adamson BJ, Meropol NJ, Ross EA. Disease Control With FOLFIRI Plus Ziv-aflibercept (zFOLFIRI) Beyond FOLFIRI Plus Bevacizumab: Case Series in Metastatic Colorectal Cancer (mCRC). Frontiers in oncology. 2019 Jan;9:142.   PMCID: PMC6426764
Ellis JL, Braun AE, Cohn JA. Management of Overactive Bladder After Treatment of Bladder Outlet Obstruction. Current Bladder Dysfunction Reports. 2019 Jan;14(3):197-204.
Falchook G, Coleman RL, Roszak A, Behbakht K, Matulonis U, Ray-Coquard I, Sawrycki P, Duska LR, Tew W, Ghamande S, Lesoin A, Schwartz PE, Buscema J, Fabbro M, Lortholary A, Goff B, Kurzrock R, Martin LP, Gray HJ, Fu SQ, Sheldon-Waniga E, Lin HM, Venkatakrishnan K, Zhou XF, Leonard EJ, Schilder RJ. Alisertib in Combination With Weekly Paclitaxel in Patients With Advanced Breast Cancer or Recurrent Ovarian Cancer A Randomized Clinical Trial. JAMA Oncol. 2019 Jan;5(1):e183773.   PMCID: PMC6439781
Feldman G, Kappes D, Mookerjee-Basu J, Freeman T, Fertala A, Parvizi J. Novel mutation in Teneurin 3 found to co-segregate in all affecteds in a multi-generation family with developmental dysplasia of the hip. Journal of orthopaedic research : official publication of the Orthopaedic Research Society. 2019 Jan;37(1):171-80.
Freund KM, Reisinger SA, LeClair AM, Yoon GH, Al-Najar SM, Young GS, Gonzalez ET, Oliveri JM, Paskett ED. Insurance Stability and Cancer Screening Behaviors. Health equity. 2019 Jan;3(1):177-82.   PMCID: PMC6608696
Frost CJ, Andrulis IL, Buys SS, Hopper JL, John EM, Terry MB, Bradbury A, Chung WK, Colbath K, Quintana N, Gamarra E, Egleston B, Galpern N, Bealin L, Glendon G, Miller LP, Daly MB. Assessing patient readiness for personalized genomic medicine. Journal of community genetics. 2019 Jan;10(1):109-20.   PMCID: PMC6325047
Gasoyan H, Tajeu G, Halpern MT, Sarwer DB. Reasons for underutilization of bariatric surgery: The role of insurance benefit design. Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery. 2019 Jan;15(1):146-51.   PMCID: PMC6441615
Gerstenhaber JA, Marcinkiewicz C, Barone FC, Sternberg M, D'Andrea MR, Lelkes PI, Feuerstein GZ. Biocompatibility studies of fluorescent diamond particles-(NV)~800nm (part V): in vitro kinetics and in vivo localization in rat liver following long-term exposure. International journal of nanomedicine. 2019 Jan;14:6451-64.   PMCID: PMC6697667
Ghatalia P, Smith CH, Winer A, Gou J, Kiedrowski LA, Slifker M, Saltzberg PD, Bubes N, Anari FM, Kasireddy V, Varshaysky A, Liu Y, Ross EA, El-Deiry WS. Clinical Utilization Pattern of Liquid Biopsies (LB) to Detect Actionable Driver Mutations, Guide Treatment Decisions and Monitor Disease Burden During Treatment of 33 Metastatic Colorectal Cancer (mCRC) Patients (pts) at a Fox Chase Cancer Center GI Oncology Subspecialty Clinic. Frontiers in oncology. 2019 Jan;8:652.   PMCID: PMC6344461
Ghosh J, Schultz B, Coutifaris C, Sapienza C. Highly variant DNA methylation in normal tissues identifies a distinct subclass of cancer patients. Advances in cancer research. 2019 Jan;142:1-22.
Greco F, Autorino R, Altieri V, Campbell S, Ficarra V, Gill I, Kutikov A, Mottrie A, Mirone V, van Poppel H. Ischemia Techniques in Nephron-sparing Surgery: A Systematic Review and Meta-Analysis of Surgical, Oncological, and Functional Outcomes. European Urology. 2019 Jan;75(3):477-91.
The above publications are sorted by year, faculty last name, and first author. Click on any highlighted author listed to find all publications attributed to that individual. Click on the publication title to see the abstract. First authors who are faculty are highlighted like this. Last authors who are faculty are highlighted like this. Other authors who are faculty are highlighted like this.

MeSH cloud from publications for the year 2019


Last updated on Monday, November 04, 2019